In the next Front Row lecture, Christian Diercks explains how chemists accelerate evolution in the lab to engineer potential new medicines. The therapeutic enzymes they create can break down or modify disease-related molecules, leading to more precise, effective medical care. Grab a seat for October 14!
Graduate Program Faculty - FL
Graduate Program
Seeing double: Designing drugs that target “twin” cancer proteins
Scripps Research scientists used knowledge about a protein to characterize drugs that selectively bind to its “twin,” or paralog.